Free Trial

Jushi (OTCMKTS:JUSHF) Issues Earnings Results, Hits Estimates

Jushi logo with Medical background

Key Points

  • Jushi Holdings reported a quarterly earnings per share (EPS) of ($0.06), matching the consensus estimate.
  • During trading, JUSHF stock remained flat at $0.65, with a significant volume of 980,341 shares exchanged.
  • Jushi is a vertically integrated cannabis company involved in the cultivation, processing, retail, and distribution of a variety of cannabis products.
  • Need Better Tools to Track Jushi? Try 5 Weeks of MarketBeat All Access for $5. Start Portfolio Tracking Now.

Jushi (OTCMKTS:JUSHF - Get Free Report) released its earnings results on Tuesday. The company reported ($0.06) earnings per share for the quarter, meeting analysts' consensus estimates of ($0.06), Zacks reports. The firm had revenue of $65.05 million for the quarter, compared to analyst estimates of $64.67 million.

Jushi Stock Down 1.2%

JUSHF stock traded down $0.01 during trading on Thursday, reaching $0.63. The company's stock had a trading volume of 177,180 shares, compared to its average volume of 207,537. Jushi has a 1 year low of $0.22 and a 1 year high of $0.69. The company's fifty day moving average is $0.38 and its 200-day moving average is $0.34. The company has a market capitalization of $123.33 million, a P/E ratio of -2.16 and a beta of -0.98.

About Jushi

(Get Free Report)

Jushi Holdings Inc, a vertically integrated cannabis company, engages in the cultivation, processing, retail, and distribution of cannabis for medical and adult-use markets. The company offers flower, extracts, concentrates, edibles, oil, pre-rolls, tinctures, capsules, softgels, cannabis-infused gummies and ultra-premium chocolate, and topicals products, as well as vaporization devices and cartridges under The Bank, The Lab, Nira+ Medicinals, Sèchè, Tasteology, and Hijinks brands.

Featured Stories

Earnings History for Jushi (OTCMKTS:JUSHF)

Should You Invest $1,000 in Jushi Right Now?

Before you consider Jushi, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Jushi wasn't on the list.

While Jushi currently has a Sell rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Elon Musk's Next Move Cover

Explore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Quantum Boom: 3 Strong Picks with Lower Risk
3 Overlooked AI Stocks That Chipmakers Can’t Live Without
Palantir & AMD Earnings: Massive Options Setups Ahead

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines